Cresco Labs, a leading multistate cannabis operator completed the acquisition of Gloucester Street Capital, a manufacturer of medical marijuana. Financial terms were not disclosed. “Cresco Labs has an incredible vision for the future of the cannabis industry, and they were the obvious choice to partner with based on their superior management team, focus on compliance and experience working across hyper-regulated industries. I believe their strategic decision making, commitment to social equity and priority for putting the patients first will make them a leader in the New York market.” Stephen Ashekian, Gloucester Street Capital CEO.